Insider Transactions in Q1 2022 at Resmed Inc (RSMDF)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-31.78%
|
$1,904,000
$238.07 P/Share
|
|
Mar 15
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.11%
|
$464,000
$58.24 P/Share
|
|
Mar 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,373,350
$242.37 P/Share
|
|
Mar 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Mar 10
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.3%
|
$602,500
$241.29 P/Share
|
|
Mar 10
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.25%
|
$142,500
$57.76 P/Share
|
|
Mar 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,544
-1.35%
|
$386,000
$250.62 P/Share
|
|
Feb 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-31.78%
|
$1,880,000
$235.81 P/Share
|
|
Feb 15
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.11%
|
$464,000
$58.24 P/Share
|
|
Feb 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,327,950
$234.06 P/Share
|
|
Feb 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Feb 10
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.3%
|
$602,500
$241.86 P/Share
|
|
Feb 10
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.25%
|
$142,500
$57.76 P/Share
|
|
Feb 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,544
-1.33%
|
$358,208
$232.87 P/Share
|
|
Jan 18
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.38%
|
$1,367,675
$241.94 P/Share
|
|
Jan 18
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.36%
|
$323,475
$57.76 P/Share
|
|
Jan 18
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
8,000
-31.78%
|
$1,976,000
$247.8 P/Share
|
|
Jan 18
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.11%
|
$464,000
$58.24 P/Share
|
|
Jan 10
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-2.3%
|
$587,500
$235.0 P/Share
|
|
Jan 10
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.25%
|
$142,500
$57.76 P/Share
|
|
Jan 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,544
-1.31%
|
$398,352
$258.52 P/Share
|